NVST - Nobel Biocare Growth-Adjusted Payback Ratio

Corporate company logo of envistaco.com (NVST)

Envista Holdings (NVST) is forced to contain the cost of consumables due to inflationary pressure on clinics. Geopolitical instability and sanctions are also complicating the global logistics of equipment. Changes in the PEG ratio demonstrate the business valuation dynamics, while the 0.97 value confirms the current level. The development strategy relies on IT acquisitions in the field of 3D diagnostics and partnerships with specialized institutions.

Nobel Biocare (NVST): Price/Earnings to Growth Ratio from 07/04/2022 to 11/16/2026

Envista Holdings (NVST) - metric breakdowns and financial figures

- current price and projected stock value:
- market capitalization statistics:
Fundamental company analysis:Envista Holdings, NVST
Core merchandise of Nobel Biocare

The PEG ratio compares the P/E ratio with earnings growth rates to determine whether the market value is fair relative to business expansion, where a value below one signals that the asset is undervalued. When analyzing the P/E growth potential metric for Envista Holdings (NVST), it is critical to consider the company's limited pricing power within the dental sector, which may constrain revenue dynamics and impact the issuer's overall investment profile.

Who Envista Holdings competes with

Price/Earnings to Growth Ratio ISRG (Intuitive Surgical)|PEG Multiple DHR (danaher.com)|Growth-Adjusted Market Cap to Net Income bd.com (BDX)|STE - Price/Earnings to Growth Ratio|WST (West Pharma) - Growth-Adjusted P/E Ratio|Baxter Healthcare (BAX) - Price/Earnings to Growth Ratio|Growth-Adjusted P/E Ratio MASI|Price/Earnings to Growth Ratio stevanatogroup.com|TFX (teleflex.com) - Company Value to Earnings Growth Ratio|Price/Earnings to Growth Multiple MMSI (Merit Medical Systems)|Company Value to Earnings Growth Ratio ICUI|Price/Earnings to Growth Ratio Dentsply XRAY|Growth-Adjusted Payback Ratio LMAT|ATRC: Price/Earnings to Growth Multiple|STAA - PEG Multiple|ChromaDex Corp (NAGE) - Price/Earnings to Growth Ratio|Price/Earnings to Growth Multiple ZimVie|ANGO (angiodynamics.com) - PEG Multiple|Price to Earnings Adjusted for Growth Rate Cerus Inc CERS|Price/Earnings to Growth Ratio Teknova (TKNO)|Monogram Orthopedics - Growth-Adjusted P/E Ratio|Sharps Technology - Price/Earnings to Growth Multiple|Company Value to Earnings Growth Ratio INFU (InfuSystem Holdings)|UTMD - Price/Earnings to Growth Ratio|Growth-Adjusted Market Cap to Net Income KORU Medical KRMD|Nyxoah (NYXH) - Price/Earnings to Growth Ratio|Price/Earnings to Growth Multiple Microbot Medical Inc.|Price/Earnings to Growth Ratio Pro-Dex|Price to Earnings Adjusted for Growth Rate Zentek Ltd ZTEK|Price/Earnings to Growth Multiple ELUT (Elutia Inc)|Price/Earnings to Growth Ratio MLSS (Milestone Scientific Corp)|PEG Multiple NXGL (NEXGEL Inc)|PEG Multiple Retractable Tech RVP|Harvard Bioscience Inc. - PEG Multiple|Growth-Adjusted Market Cap to Net Income Femasys Corp FEMY|MHUA: PEG Multiple|Price/Earnings to Growth Multiple Predictive Oncology|Price/Earnings to Growth Multiple CJMB|ATRI: Growth-Adjusted Payback Ratio|Price/Earnings to Growth Multiple NURO (NeuroMetrix, Inc.)